Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig M Kessler

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Blood Advances|October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohortJacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Research and Practice in Thrombosis and Haemostasis|April 16, 2025
Development of a novel gene editing lexicon for hemophilia: methodology and resultsCraig M Kessler, Leonard A Valentino, Courtney D Thornburg, et al.
Blood|August 15, 2002
End-stage liver disease in persons with hemophilia and transfusion-associated infectionsJames J Goedert, M Elaine Eyster, Michael M Lederman, et al.
Blood Advances|June 14, 2018
A cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L Sood, Dunlei Cheng, Margaret Ragni, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Blood Advances|October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohortJacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
The New England Journal of Medicine|February 26, 2003
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker, Samuel Z Goldhaber, Ellie Danielson, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Research and Practice in Thrombosis and Haemostasis|April 16, 2025
Development of a novel gene editing lexicon for hemophilia: methodology and resultsCraig M Kessler, Leonard A Valentino, Courtney D Thornburg, et al.
Blood|August 15, 2002
End-stage liver disease in persons with hemophilia and transfusion-associated infectionsJames J Goedert, M Elaine Eyster, Michael M Lederman, et al.
Blood Advances|June 14, 2018
A cross-sectional analysis of cardiovascular disease in the hemophilia populationSuman L Sood, Dunlei Cheng, Margaret Ragni, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Genes and Immunity|September 25, 2025
Correction: A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Pageof 9